Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Health economics of chronic infectious diseases: the example of hepatitis C].
Wasem J, Sroczynski G, Aidelsburger P, Buchberger B, Hessel F, Conrads-Frank A, Peters-Blöchinger A, Kurth BM, Wong JB, Rossol S, Siebert U. Wasem J, et al. Among authors: aidelsburger p. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2006 Jan;49(1):57-63. doi: 10.1007/s00103-005-1190-7. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2006. PMID: 16341606 German.
Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon alpha-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany.
Siebert U, Sroczynski G, Wasem J, Greiner W, Ravens-Sieberer U, Aidelsburger P, Kurth BM, Bullinger M, von der Schulenburg JM, Wong JB, Rossol S. Siebert U, et al. Among authors: aidelsburger p. Eur J Health Econ. 2005 Jun;6(2):112-23. doi: 10.1007/s10198-005-0280-7. Eur J Health Econ. 2005. PMID: 15902546
Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines.
Siebert U, Sroczynski G, Aidelsburger P, Rossol S, Wasem J, Manns MP, McHutchison JG, Wong JB. Siebert U, et al. Among authors: aidelsburger p. Pharmacoeconomics. 2009;27(4):341-54. doi: 10.2165/00019053-200927040-00006. Pharmacoeconomics. 2009. PMID: 19485429 Clinical Trial.
Antiviral treatment initiation costs in chronic hepatitis C.
Siebert U, Wasem J, Rossol S, Sroczynski G, Aidelsburger P, Ravens-Sieberer U, Kurth BM, Manns MP, McHutchison JG, Wong JB. Siebert U, et al. Among authors: aidelsburger p. Gut. 2005 Jan;54(1):172-3. Gut. 2005. PMID: 15591531 Free PMC article. No abstract available.
Cost-effectiveness of childhood rotavirus vaccination in Germany.
Aidelsburger P, Grabein K, Böhm K, Dietl M, Wasem J, Koch J, Ultsch B, Weidemann F, Wichmann O. Aidelsburger P, et al. Vaccine. 2014 Apr 7;32(17):1964-74. doi: 10.1016/j.vaccine.2014.01.061. Epub 2014 Feb 20. Vaccine. 2014. PMID: 24561052
Budget impact analysis on the introduction of a guideline based hepatitis B and C screening into a routine check-up in the German primary care setting.
Barth C, Neusser S, Biermann J, Wasem J, Berg T, Wiegand J, Wolffram I, Petroff D, Aidelsburger P, Grünbauer A, Neumann A. Barth C, et al. Among authors: aidelsburger p. Scand J Gastroenterol. 2018 Jan;53(1):76-82. doi: 10.1080/00365521.2017.1390599. Epub 2017 Oct 24. Scand J Gastroenterol. 2018. PMID: 29065740
[Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].
Krauth C, John J, Aidelsburger P, Brüggenjürgen B, Hansmeier T, Hessel F, Kohlmann T, Moock J, Rothgang H, Schweikert B, Seitz R, Wasem J; AG Methoden der gesundheitsökonomischen Evaluation. Krauth C, et al. Among authors: aidelsburger p. Gesundheitswesen. 2008 Jun;70(6):e1-16. doi: 10.1055/s-2008-1077059. Gesundheitswesen. 2008. PMID: 18661452 German.
23 results